Search

Author/Creator Bahary, Nathan

22. Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer. Issue 4 (16th August 2013)

Authors:
Boone, Brian A.; Steve, Jennifer; Krasinskas, Alyssa M.; Zureikat, Amer H.; Lembersky, Barry C.; Gibson, Michael K.; Stoller, Ronald G.; Zeh, Herbert J.; Bahary, Nathan
Journal:
Journal of surgical oncology
Issue:
Volume 108:Issue 4(2013:Sep. 15)
Page Start:
236
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. Overweight or Obese Individuals at Eighteen Years of Age Develop Pancreatic Adenocarcinoma at a Significantly Earlier Age. (5th June 2018)

Authors:
Chao, David T.; Shah, Nilesh H.; Zeh, Herbert J.; Singhi, Aatur D.; Bahary, Nathan; McGrath, Kevin M.; Fasanella, Kenneth E.; Zureikat, Amer H.; Whitcomb, David C.; Brand, Randall E.
Other Names:
Silvestris Nicola Academic Editor.
Journal:
Gastroenterology research and practice
Issue:
Volume 2018(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

24. Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma. Issue 3 (24th April 2021)

Authors:
Narayanan, Sowmya; AlMasri, Samer; Zenati, Mazen; Nassour, Ibrahim; Chopra, Asmita; Rieser, Caroline; Smith, Katelyn; Oyefusi, Vivianne; Daum, Tracy; Bahary, Nathan; Bartlett, David; Lee, Kenneth; Zureikat, Amer; Paniccia, Alessandro
Journal:
Journal of surgical oncology
Issue:
Volume 124:Issue 3(2021)
Page Start:
308
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

25. Smad4 Loss in Esophageal Adenocarcinoma Is Associated With an Increased Propensity for Disease Recurrence and Poor Survival. (April 2015)

Authors:
Singhi, Aatur D.; Foxwell, Tyler J.; Nason, Katie; Cressman, Kristi L.; McGrath, Kevin M.; Sun, Weijing; Bahary, Nathan; Zeh, Herbert J.; Levy, Ryan M.; Luketich, James D.; Davison, Jon M.
Journal:
American journal of surgical pathology
Issue:
Volume 39:Number 4(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

26. Smad4 Loss in Esophageal Adenocarcinoma Is Associated With an Increased Propensity for Disease Recurrence and Poor Survival. (April 2015)

Authors:
Singhi, Aatur D.; Foxwell, Tyler J.; Nason, Katie; Cressman, Kristi L.; McGrath, Kevin M.; Sun, Weijing; Bahary, Nathan; Zeh, Herbert J.; Levy, Ryan M.; Luketich, James D.; Davison, Jon M.
Journal:
American journal of surgical pathology
Issue:
Volume 39:Number 4(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

27. SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma. Issue 5 (18th May 2021)

Authors:
Fei, Naomi; Wen, Sijin; Ramanathan, Rajesh; Hogg, Melissa E.; Zureikat, Amer H.; Lotze, Michael T.; Bahary, Nathan; Singhi, Aatur D.; Zeh, Herbert J.; Boone, Brian A.
Journal:
Clinical and translational science
Issue:
Volume 14:Issue 5(2021)
Page Start:
1822
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

29. The use of angiotensin system inhibitors correlates with longer survival in resected pancreatic adenocarcinoma patients. Issue 3 (March 2023)

Authors:
Liu, Hao; Nassour, Ibrahim; Lebowitz, Steven; D'Alesio, Mark; Hampton, Erica; Desilva, Annissa; Hammad, Abdulrahman; AlMasri, Samer; Khachfe, Hussein H.; Singhi, Aatur; Bahary, Nathan; Lee, Kenneth; Zureikat, Amer; Paniccia, Alessandro
Journal:
HPB
Issue:
Volume 25:Issue 3(2023)
Page Start:
320
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗